Literature DB >> 28962832

The convergent roles of the nuclear factor I transcription factors in development and cancer.

Kok-Siong Chen1, Jonathan W C Lim1, Linda J Richards2, Jens Bunt3.   

Abstract

The nuclear factor I (NFI) transcription factors play important roles during normal development and have been associated with developmental abnormalities in humans. All four family members, NFIA, NFIB, NFIC and NFIX, have a homologous DNA binding domain and function by regulating cell proliferation and differentiation via the transcriptional control of their target genes. More recently, NFI genes have also been implicated in cancer based on genomic analyses and studies of animal models in a variety of tumours across multiple organ systems. However, the association between their functions in development and in cancer is not well described. In this review, we summarise the evidence suggesting a converging role for the NFI genes in development and cancer. Our review includes all cancer types in which the NFI genes are implicated, focusing predominantly on studies demonstrating their oncogenic or tumour-suppressive potential. We conclude by presenting the challenges impeding our understanding of NFI function in cancer biology, and demonstrate how a developmental perspective may contribute towards overcoming such hurdles.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Development; NFI; Nuclear factor I; Nuclear factor one; Transcription factor; Tumorigenesis

Mesh:

Substances:

Year:  2017        PMID: 28962832     DOI: 10.1016/j.canlet.2017.09.015

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  24 in total

1.  Transcription factors NFIA and NFIB induce cellular differentiation in high-grade astrocytoma.

Authors:  Kok-Siong Chen; Caitlin R Bridges; Zorana Lynton; Jonathan W C Lim; Brett W Stringer; Revathi Rajagopal; Kum-Thong Wong; Dharmendra Ganesan; Hany Ariffin; Bryan W Day; Linda J Richards; Jens Bunt
Journal:  J Neurooncol       Date:  2019-11-23       Impact factor: 4.130

2.  Transcription factor NFIC functions as a tumor suppressor in lung squamous cell carcinoma progression by modulating lncRNA CASC2.

Authors:  Hong Zhang; Zhilin Luo; JianMing Tang; Jie Tian; Yajie Xiao; Chao Sun; Tianhu Wang
Journal:  Cell Cycle       Date:  2022-01-05       Impact factor: 4.534

3.  A miR-9-5p/FOXO1/CPEB3 Feed-Forward Loop Drives the Progression of Hepatocellular Carcinoma.

Authors:  Hui Hu; Wei Huang; Hong Zhang; Jianye Li; Qiong Zhang; Ya-Ru Miao; Fei-Fei Hu; Lu Gan; Zhenhong Su; Xiangliang Yang; An-Yuan Guo
Journal:  Cells       Date:  2022-07-05       Impact factor: 7.666

4.  Identification of Serum Exosome-Derived circRNA-miRNA-TF-mRNA Regulatory Network in Postmenopausal Osteoporosis Using Bioinformatics Analysis and Validation in Peripheral Blood-Derived Mononuclear Cells.

Authors:  Qianqian Dong; Ziqi Han; Limin Tian
Journal:  Front Endocrinol (Lausanne)       Date:  2022-06-09       Impact factor: 6.055

5.  Transcriptional profiling reveals gland-specific differential expression in the three major salivary glands of the adult mouse.

Authors:  Xin Gao; Maria S Oei; Catherine E Ovitt; Murat Sincan; James E Melvin
Journal:  Physiol Genomics       Date:  2018-01-26       Impact factor: 3.107

6.  Increased nuclear factor I/B expression in prostate cancer correlates with AR expression.

Authors:  Jagpreet S Nanda; Wisam N Awadallah; Sarah E Kohrt; Petra Popovics; Justin M M Cates; Janni Mirosevich; Peter E Clark; Giovanna A Giannico; Magdalena M Grabowska
Journal:  Prostate       Date:  2020-07-21       Impact factor: 4.104

7.  Serum nuclear factor IB as a novel and noninvasive indicator in the diagnosis of secondary hyperparathyroidism.

Authors:  Jian'gen Yu; Yu Song; Aihua Yang; Xiaoyun Zhang; Lin Li
Journal:  J Clin Lab Anal       Date:  2021-05-15       Impact factor: 2.352

8.  Deletion of NFIX results in defective progression through meiosis within the mouse testis†.

Authors:  Raul Ayala Davila; Cassy Spiller; Danyon Harkins; Tracey Harvey; Philip W Jordan; Richard M Gronostajski; Michael Piper; Josephine Bowles
Journal:  Biol Reprod       Date:  2022-06-13       Impact factor: 4.161

Review 9.  Targeting Transcription Factors for Cancer Treatment.

Authors:  Mélanie Lambert; Samy Jambon; Sabine Depauw; Marie-Hélène David-Cordonnier
Journal:  Molecules       Date:  2018-06-19       Impact factor: 4.411

10.  Elevated RUNX1 is a prognostic biomarker for human head and neck squamous cell carcinoma.

Authors:  Xiaodong Feng; Zhiwei Zheng; Yi Wang; Guanghui Song; Lu Wang; Zhijun Zhang; Jinxia Zhao; Qing Wang; Limin Lun
Journal:  Exp Biol Med (Maywood)       Date:  2020-11-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.